P1 (Pramipexole dihydrochloride 0.125 mg)

Pill imprint P1 has been identified as Pramipexole dihydrochloride 0.125 mg.

Pramipexole is used in the treatment of restless legs syndrome; parkinson's disease; periodic limb movement disorder; tardive dyskinesia and belongs to the drug class dopaminergic antiparkinsonism agents. Risk cannot be ruled out during pregnancy. Pramipexole 0.125 mg is not subject to the Controlled Substances Act.

See also related documents.

Imprint Search

Images for P1

Pramipexole dihydrochloride 0.125 mg P1
Pramipexole dihydrochloride 0.125 mg P1
Pramipexole dihydrochloride
Imprint:
P1
Strength:
0.125 mg
Color:
Pink
Shape:
Capsule-shape
Availability:
Prescription only
Drug Class:
Dopaminergic antiparkinsonism agents
Pregnancy Category:
C - Risk cannot be ruled out
CSA Schedule:
N - Not a controlled drug
Manufacturer:
Zydus Pharmaceuticals
National Drug Code (NDC):
68382-0196
Inactive Ingredients:
D&C Red No. 27
magnesium stearate
mannitol
povidone
pregelatinized corn starch
silicon dioxide

View Details Print Page

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2014 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide
(web4)